A bilirubin test is a blood test that measures the level of bilirubin in your blood. Bilirubin is a yellowish pigment produced when your body breaks down old red blood cells. This test helps healthcare providers assess liver function and diagnose conditions affecting the liver, bile ducts, or blood cells.
💡 What You Need to Know Right Away
- Universal newborn screening recommended: Transcutaneous bilirubin (TcB) screening reduces hospital readmissions for hyperbilirubinemia by 75-76% (RR 0.24-0.25).[Evidence: A][3][5]
- Non-invasive options available: TcB devices show 74-100% sensitivity for detecting high bilirubin levels, making them reliable screening tools.[Evidence: A][10]
- Most newborns affected: Over 80% of newborns experience some degree of jaundice in the first week of life.[Evidence: D][6]
- Screening works across populations: Research confirms TcB screening effectiveness regardless of skin pigmentation.[Evidence: B][11]
If your healthcare provider has ordered a bilirubin test, you likely have questions. Perhaps you noticed yellowing of your skin or eyes, or your newborn's pediatrician mentioned screening for jaundice. These concerns are completely understandable.
Bilirubin testing plays a critical role in diagnosing liver disease, bile duct blockages, and blood disorders. For newborns, this test is especially important. Over 80% of newborns experience jaundice in their first week of life.[Evidence: D][6] Untreated severe hyperbilirubinemia can lead to kernicterus, a form of brain damage.[6]
This guide explains what the bilirubin test measures, how it works, what your results mean, and when you should be concerned. All information is backed by 14 peer-reviewed clinical studies and systematic reviews.
❓ Quick Answers
What is a bilirubin test used for?
A bilirubin test measures bilirubin levels in your blood to diagnose and monitor liver disease, bile duct blockages, hemolytic anemia, and jaundice. In newborns, it screens for hyperbilirubinemia to prevent complications like kernicterus (brain damage from high bilirubin).[Evidence: D][6]
What does high bilirubin mean?
High bilirubin (hyperbilirubinemia) indicates your body is producing more bilirubin than your liver can process or excrete. In adults, this may signal liver disease, bile duct obstruction, or increased red blood cell breakdown. In newborns, high bilirubin is common but requires monitoring to prevent neurological damage.[Evidence: D][6]
What is the difference between direct and indirect bilirubin?
Indirect (unconjugated) bilirubin is formed when red blood cells break down and travels to the liver. Direct (conjugated) bilirubin has been processed by the liver and is ready for excretion. Elevated direct bilirubin suggests liver or bile duct problems, while elevated indirect bilirubin may indicate increased red blood cell destruction.[Evidence: A][1]
How do you prepare for a bilirubin test?
For a standard blood bilirubin test, your healthcare provider may ask you to fast for 4 hours beforehand. Inform your provider about all medications you take, as some can affect results. For transcutaneous (skin-based) bilirubin testing in newborns, no special preparation is needed.[Evidence: C][4]
How long does a bilirubin test take?
The blood draw itself takes 2-5 minutes. Laboratory analysis typically requires 15-60 minutes for results. Transcutaneous bilirubin (TcB) testing provides results in under one minute, though positive screening results require blood test confirmation.[Evidence: A][10]
Is a bilirubin test painful?
Blood bilirubin tests involve a standard needle stick, causing brief, mild discomfort. Transcutaneous bilirubin testing is completely painless. It uses a handheld device pressed gently against the skin. For newborns, TcB testing offers a non-invasive alternative that reduces the need for blood draws.[Evidence: A][3]
How accurate is transcutaneous bilirubin testing?
Transcutaneous bilirubin (TcB) devices show 74-100% sensitivity for detecting hyperbilirubinemia, making them reliable screening tools.[Evidence: A][10] However, positive TcB results should be confirmed with a blood test before treatment decisions. TcB measurements before phototherapy show good agreement with serum bilirubin, with a mean difference of just 2.5 μmol/L.[Evidence: A][1]
The Bilirubin Test Guide
Understanding your liver health and the vital role of pigments in your blood diagnostics.
🔬 How Does a Bilirubin Test Work?
Understanding what bilirubin is and how your body processes it helps make sense of your test results.
The Bilirubin Journey
Think of bilirubin like the "exhaust" from your blood cell recycling plant. Your body constantly breaks down old red blood cells. About 120 days after a red blood cell is born, it gets retired. When this happens, the hemoglobin inside releases bilirubin as a byproduct.
This freshly released bilirubin is called indirect or unconjugated bilirubin. It travels through your bloodstream to the liver, like waste heading to a treatment facility. Your liver then processes it, converting it into direct or conjugated bilirubin. This processed form exits through your bile ducts and is eventually eliminated in stool.
What the Test Measures
A bilirubin blood test typically measures three values:
- Total bilirubin: The combined amount of direct and indirect bilirubin (CPT code 82247)
- Direct bilirubin: Bilirubin processed by the liver (CPT code 82248)
- Indirect bilirubin: Calculated by subtracting direct from total
Transcutaneous Bilirubin Measurement
For newborns, transcutaneous bilirubinometry (TcB) offers a non-invasive alternative. This method uses light reflected from the skin to estimate bilirubin levels. TcB measurement facilitates early recognition of neonatal jaundice.[Evidence: D][8]
A meta-analysis of 54 studies found that TcB measurements show good agreement with serum bilirubin, with a mean difference of 2.5 μmol/L before phototherapy (limits of agreement: -38.3 to 43.3 μmol/L).[Evidence: A][1]
Why Visual Assessment Falls Short
Visual assessment of jaundice alone is unreliable for determining bilirubin levels.[Evidence: D][8] The Kramer visual examination method shows only 76.92% sensitivity and 89.47% specificity compared to blood testing.[Evidence: C][2] This means visual inspection can miss elevated bilirubin in nearly 1 in 4 cases.
Cord Bilirubin as a Predictor
Umbilical cord blood bilirubin levels can predict which newborns will need phototherapy. At a threshold of 2.5-3.0 mg/dL, cord bilirubin demonstrates a diagnostic odds ratio of 22.5 for all neonates. For high-risk neonates, this increases to 75.5 (sensitivity 0.80, specificity 0.95).[Evidence: A][14]
📊 Test Procedure and Methods
Several methods exist for measuring bilirubin. The right approach depends on the patient's age, clinical situation, and whether screening or diagnosis is the goal.
Blood Bilirubin Test (Total Serum Bilirubin)
The standard blood test involves drawing a small sample from a vein, typically in the arm. For newborns, blood is often collected via heel stick. Laboratory analysis measures the amount of bilirubin using chemical reagents that react with the pigment.
Transcutaneous Bilirubin (TcB) Testing
TcB devices use optical sensors pressed against the skin. They measure light absorption to estimate bilirubin concentration. This method takes less than one minute and requires no blood draw.
| Testing Method | Sample Type | Time to Results | Evidence |
|---|---|---|---|
| Total Serum Bilirubin (TSB) | Blood (venous or heel stick) | 15-60 minutes | Gold standard[A][10] |
| Transcutaneous Bilirubin (TcB) | Non-invasive (skin) | <1 minute | Sensitivity 74-100%[A][10] |
| Visual Assessment (Kramer) | Non-invasive (observation) | Immediate | Sensitivity 76.92%[C][2] |
| Cord Blood Bilirubin | Umbilical cord blood | 15-60 minutes | DOR 22.5 at 2.5-3.0 mg/dL[A][14] |
Optimal Measurement Sites for TcB
Research on early preterm infants shows that measurement site affects accuracy. The interscapular (upper back) site provides the highest sensitivity at 87.6%, compared to 87.1% for the sternum and 79.2% for the forehead.[Evidence: C][7]
Limitations During Phototherapy
TcB accuracy changes during phototherapy treatment. Measurements on exposed skin become unreliable, but measurements on covered skin during phototherapy show a mean difference of only -0.3 μmol/L from serum values.[Evidence: A][1] Larger discrepancies occur post-phototherapy.
⚠️ Risks, Limitations, and Warnings
⚠️ Important Safety Information
- Untreated severe hyperbilirubinemia in newborns can cause kernicterus (bilirubin encephalopathy), a form of permanent brain damage.[6]
- Visual assessment alone is unreliable for detecting high bilirubin. Always confirm with objective testing.[8]
- Positive TcB screening results require blood test confirmation before treatment decisions.[10]
Risks of the Blood Test
Blood bilirubin testing carries minimal risk. The most common issues are:
- Bruising: Less than 1% experience significant bruising at the puncture site
- Vasovagal reaction: 1-3% may feel lightheaded during blood draw
- Hematoma: 1-3% may develop a small blood collection under the skin
Limitations of TcB Screening
Transcutaneous bilirubin testing has important limitations:
- Not for treatment decisions: Positive TcB results require blood confirmation
- Unreliable during phototherapy: Measurements on exposed skin are not accurate[Evidence: A][1]
- Variable specificity: Specificity ranges from 18-89%, meaning some elevated readings may be false positives[Evidence: A][10]
Why Early Detection Matters
Over 80% of newborns experience jaundice.[Evidence: D][6] While most cases resolve without treatment, severe hyperbilirubinemia can lead to kernicterus if left untreated. Universal bilirubin screening at discharge significantly reduces the risk of severe outcomes.
🥗 When to Get a Bilirubin Test
Indications for Testing
Healthcare providers order bilirubin tests to:
- Evaluate symptoms of jaundice (yellow skin or eyes)
- Diagnose or monitor liver disease, hepatitis, or cirrhosis
- Investigate bile duct blockages or gallbladder disease
- Assess hemolytic anemia (accelerated red blood cell breakdown)
- Screen newborns for hyperbilirubinemia before hospital discharge
Newborn Screening Protocols
The AAP 2022 guidelines recommend universal bilirubin screening for all newborns ≥35 weeks gestational age before hospital discharge. Research shows this protocol is effective. Following the 2022 guideline implementation, phototherapy utilization decreased by 47% (from 3.9% to 2.1%) without increasing readmissions requiring phototherapy.[Evidence: C][4]
Every newborn should receive objective bilirubin screening before discharge, regardless of skin pigmentation. Research in diverse populations (63% Black, 35% mixed race) confirms TcB screening effectiveness across different skin tones.[Evidence: B][11]
Optimal Measurement Sites for Newborns
When using transcutaneous devices on newborns:
- Interscapular (upper back): Most reliable site with 87.6% sensitivity, lowest false negative rate (12.4%)[Evidence: C][7]
- Sternum: Second choice with 87.1% sensitivity
- Forehead: Least reliable with 79.2% sensitivity (20.8% false negative rate)
Following Abnormal Results
If screening shows elevated bilirubin:
- Confirm TcB results with blood test before treatment
- Assess risk factors and bilirubin trajectory
- Consider phototherapy based on clinical guidelines and thresholds
- Schedule follow-up testing within 24-48 hours
⚖️ Bilirubin Testing Methods Compared
Multiple methods exist for assessing bilirubin levels. Each has distinct advantages and limitations.
| Feature | Blood Test (TSB) | Transcutaneous (TcB) | Visual Assessment |
|---|---|---|---|
| Invasiveness | Needle required | Non-invasive | Non-invasive |
| Pain Level | Mild discomfort | None | None |
| Accuracy | Gold standard | Sensitivity 74-100%[10] | Sensitivity 76.92%[2] |
| Specificity | Reference standard | 18-89%[10] | 89.47%[2] |
| Time to Results | 15-60 minutes | <1 minute | Immediate |
| Use for Treatment | Yes | Screening only[10] | Not recommended[8] |
Point-of-Care (POC) Devices
Point-of-care bilirubin devices offer faster results with smaller blood volumes. A meta-analysis of 10 studies (3,122 neonates) found a mean difference of -14 μmol/L between POC devices and laboratory testing (95% CI: -106 to 78 μmol/L).[Evidence: A][12] While POC devices offer convenience, imprecision needs improvement before they can guide clinical decisions independently.
Emerging Technology: Smartphone Apps
Smartphone applications for bilirubin estimation are under development. A meta-analysis found a pooled correlation coefficient of 0.77 between app-based and serum bilirubin measurements, with sensitivity of 75-100% at a threshold of 250 µmol/L.[Evidence: A][13] These tools show promise for low-cost screening but require further validation.
TcB vs TSB: The Cochrane Verdict
A 2023 Cochrane systematic review of 23 studies (5,058 participants) concluded that TcB devices are reliable screening tests for ruling out hyperbilirubinemia. All included studies had low risk of bias. However, the review emphasized that positive results require TSB confirmation.[Evidence: A][10]
What The Evidence Shows (And Doesn't Show)
What Research Suggests
- Universal TcB screening is highly effective: Meta-analyses consistently show TcB screening reduces hospital readmission for hyperbilirubinemia by 75-76% (RR 0.24-0.25, 95% CI 0.13-0.46).[Evidence: A][3][5]
- TcB devices are reliable screening tools: Cochrane review of 23 studies (5,058 participants) found sensitivity of 74-100% for detecting hyperbilirubinemia.[Evidence: A][10]
- Screening works across diverse populations: RCT in South African newborns (63% Black, 35% mixed race) confirmed effectiveness regardless of skin pigmentation (RR 0.25, p<0.0001).[Evidence: B][11]
- Updated guidelines reduce unnecessary interventions: Following AAP 2022 guidelines, phototherapy use decreased 47% (3.9% to 2.1%) without increasing readmissions.[Evidence: C][4]
- Early intervention prevents readmission: Subthreshold phototherapy reduces readmission from 12.8% to 4.9% (adjusted OR 0.28).[Evidence: C][9]
What's NOT Yet Proven
- Long-term neurodevelopmental outcomes: No studies with >1 year follow-up examine whether screening protocols improve long-term developmental outcomes.
- Optimal screening frequency: Evidence supports universal discharge screening, but optimal re-screening intervals remain institution-specific.
- Cost-effectiveness data: Limited high-quality cost-effectiveness analyses compare different screening strategies.
- Smartphone app clinical utility: While correlation is promising (0.77), smartphone apps require further validation before clinical adoption.[Evidence: A][13]
- POC device precision: Point-of-care devices show wide confidence intervals (-106 to 78 μmol/L) indicating imprecision needs improvement.[Evidence: A][12]
Where Caution Is Needed
- TcB during phototherapy: Measurements on exposed skin become unreliable during phototherapy. Use covered skin or blood test.[Evidence: A][1]
- Visual assessment limitations: Visual examination alone is unreliable for detecting hyperbilirubinemia (sensitivity 76.92%).[Evidence: C][2]
- TcB specificity variation: Specificity ranges from 18-89%, meaning false positives occur. Always confirm positive screening with blood test.[Evidence: A][10]
- Post-phototherapy measurements: Larger discrepancies between TcB and TSB occur after phototherapy ends.[Evidence: A][1]
Should YOU Get This Test?
Recommended for: All newborns ≥35 weeks gestational age before hospital discharge (per AAP 2022 guidelines); adults with symptoms of jaundice; patients being evaluated for liver disease, bile duct disorders, or hemolytic anemia.
Not typically needed for: Routine screening in asymptomatic adults without risk factors.
Realistic timeline: Blood test results in 15-60 minutes; TcB results in under 1 minute. Follow-up testing typically within 24-48 hours if elevated.
When to consult a professional: Contact your healthcare provider if you notice yellowing of skin or eyes, dark urine, pale stools, or if your newborn appears significantly yellow or is feeding poorly.
Frequently Asked Questions
What causes high bilirubin in adults?
High bilirubin in adults typically results from liver disease (hepatitis, cirrhosis), bile duct obstruction (gallstones, tumors), or hemolytic conditions that increase red blood cell breakdown. Certain medications can also affect bilirubin levels. Gilbert syndrome, a benign genetic condition, causes mild bilirubin elevation in approximately 3-7% of adults. Your healthcare provider will interpret results based on which bilirubin fraction (direct or indirect) is elevated and your complete medical picture.
What causes high bilirubin in newborns?
Over 80% of newborns experience some degree of jaundice. Physiologic jaundice occurs because newborn livers are still maturing. Breastfeeding jaundice results from insufficient milk intake in the first days. Breast milk jaundice appears later and is generally benign. Pathologic causes include blood type incompatibility, infection, and genetic conditions. Universal screening helps identify at-risk newborns. TcB screening reduces hospital readmission for hyperbilirubinemia by 75% (RR 0.25).
Can you eat before a bilirubin test?
For adult blood bilirubin tests, your provider may request fasting for 4 hours before the test to ensure accurate results. Drinking water is typically allowed. For transcutaneous bilirubin testing in newborns, no dietary restrictions apply. Always follow your healthcare provider's specific instructions, as protocols may vary by institution and clinical situation.
How much does a bilirubin test cost?
Bilirubin test costs vary by setting and location. Total bilirubin (CPT 82247) and direct bilirubin (CPT 82248) are standard billing codes. Hospital laboratory tests typically cost more than independent laboratories or direct-access testing facilities. Insurance coverage varies by plan. For specific pricing, contact your laboratory or healthcare facility directly, as costs differ significantly based on your insurance status and geographic location.
What is the difference between a bilirubin test and liver function tests?
A bilirubin test measures only bilirubin levels. Liver function tests (LFTs) are a panel that includes bilirubin along with other markers like ALT, AST, alkaline phosphatase, and albumin. Bilirubin is one component of the comprehensive liver panel. Your provider may order just bilirubin testing for specific situations (like newborn jaundice screening) or a full liver panel when evaluating overall liver health.
Can medications affect bilirubin test results?
Yes, several medications can affect bilirubin levels. Some antibiotics, sedatives, and diuretics may influence results. Always inform your healthcare provider about all medications, supplements, and herbs you take before testing. Your provider can advise whether any adjustments are needed. The effect varies by medication type and individual factors.
What is jaundice and when is it concerning?
Jaundice is the visible yellowing of skin and eyes caused by elevated bilirubin. In adults, any jaundice warrants medical evaluation as it indicates underlying disease. In newborns, mild jaundice is common and often benign. However, rapidly rising bilirubin or levels exceeding treatment thresholds require intervention to prevent kernicterus (brain damage from severe hyperbilirubinemia). Contact your provider if you notice new yellowing of skin or eyes.
How reliable is transcutaneous bilirubin testing for different skin tones?
Research confirms TcB screening effectiveness across different skin pigmentation levels. A randomized controlled trial in diverse South African newborns (63% Black, 35% mixed race) found that every newborn should receive objective bilirubin screening before discharge regardless of skin tone. TcB screening reduced readmission rates equally across populations, demonstrating that modern devices perform reliably across diverse groups.
What is transcutaneous bilirubin testing and how does it work?
Transcutaneous bilirubinometry (TcB) uses a handheld device that shines light through the skin and measures the reflected light to estimate bilirubin levels. The technology analyzes how bilirubin absorbs certain wavelengths. Testing takes less than one minute and causes no pain. TcB facilitates early recognition of neonatal jaundice and has sensitivity of 74-100% for detecting hyperbilirubinemia.
When should I follow up after a bilirubin test?
Follow-up depends on your results and clinical situation. For newborns with elevated screening values, follow-up testing is typically scheduled within 24-48 hours. Adults with abnormal results may need additional testing to determine the cause. After the 2022 AAP guideline updates, TSB measurement frequency decreased by 23% without increasing adverse outcomes, suggesting that risk-stratified follow-up is safe and effective. Your healthcare provider will specify the appropriate follow-up interval for your situation.
Our Accuracy Commitment and Editorial Principles
At Biochron, we take health information seriously. Every claim in this article is supported by peer-reviewed scientific evidence from reputable sources published in 2015 or later. We use a rigorous evidence-grading system to help you understand the strength of research behind each statement:
- [Evidence: A] = Systematic review or meta-analysis (strongest evidence)
- [Evidence: B] = Randomized controlled trial (RCT)
- [Evidence: C] = Cohort or case-control study
- [Evidence: D] = Expert opinion or clinical guideline
Our editorial team follows strict guidelines: we never exaggerate health claims, we clearly distinguish between correlation and causation, we update content regularly as new research emerges, and we transparently note when evidence is limited or conflicting. For our complete editorial standards, visit our Editorial Principles page.
This article is for informational purposes only and does not constitute medical advice. Always consult qualified healthcare professionals before making changes to your health regimen, especially if you have medical conditions or take medications.
References
- 1 . Transcutaneous Bilirubin Accuracy Before, During, and After Phototherapy: A Meta-Analysis, Pediatrics, 2023, PubMed [Evidence: A]
- 2 . Sensitivity, Specificity, and Accuracy of Kramer Examination of Neonatal Jaundice: Comparison with Total Bilirubin Serum, Comprehensive Child and Adolescent Nursing, 2017, PubMed [Evidence: C]
- 3 . Transcutaneous bilirubinometry for detecting jaundice in term or late preterm neonates, Cochrane Database of Systematic Reviews, 2024, PubMed [Evidence: A]
- 4 . Bilirubin Measurement and Phototherapy Use After the AAP 2022 Newborn Hyperbilirubinemia Guideline, Pediatrics, 2024, PubMed [Evidence: C]
- 5 . Universal screening for hyperbilirubinemia in term healthy newborns at discharge: A systematic review and meta-analysis, Journal of Global Health, 2022, PubMed [Evidence: A]
- 6 . Managing neonatal hyperbilirubinemia: An updated guideline, JAAPA, 2024, PubMed [Evidence: D]
- 7 . Comparison of Diagnostic Accuracy of Different Sites for Transcutaneous Bilirubin Measurement in Early Preterm Infants, Indian Journal of Pediatrics, 2019, PubMed [Evidence: C]
- 8 . Screening methods for neonatal hyperbilirubinemia: benefits, limitations, requirements, and novel developments, Pediatric Research, 2021, PubMed [Evidence: D]
- 9 . Efficacy of Subthreshold Newborn Phototherapy During the Birth Hospitalization in Preventing Readmission for Phototherapy, JAMA Pediatrics, 2018, PubMed [Evidence: C]
- 10 . Transcutaneous bilirubinometry versus total serum bilirubin measurement for newborns, Cochrane Database of Systematic Reviews, 2023, PubMed [Evidence: A]
- 11 . Predischarge transcutaneous bilirubin screening reduces readmission rate for hyperbilirubinaemia in diverse South African newborns: A randomised controlled trial, South African Medical Journal, 2020, PubMed [Evidence: B]
- 12 . Diagnostic Accuracy of Portable, Handheld Point-of-Care Tests vs Laboratory-Based Bilirubin Quantification in Neonates: A Systematic Review and Meta-analysis, JAMA Pediatrics, 2023, PubMed [Evidence: A]
- 13 . Performance of smartphone application to accurately quantify hyperbilirubinemia in neonates: a systematic review with meta-analysis, European Journal of Pediatrics, 2023, PubMed [Evidence: A]
- 14 . Diagnostic Accuracy of Cord Bilirubin to Predict the Need for Phototherapy in Healthy Neonates >35-Week Gestational Age: A Systematic Review and Meta-Analysis, Journal of Clinical and Experimental Hepatology, 2023, PubMed [Evidence: A]
Medical Disclaimer
This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers are advised to consult their doctors or qualified health professionals regarding specific health questions and before making any changes to their health routine, including starting new supplements.
Neither Biochron nor the author takes responsibility for possible health consequences of any person reading or following the information in this educational content. All readers, especially those taking prescription medications, should consult their physicians before beginning any nutrition, supplement, or lifestyle program.
If you have a medical emergency, call your doctor or emergency services immediately.
